Immediate Impact
52 standout
Citing Papers
Datopotamab Deruxtecan in Advanced or Metastatic HR+/HER2– and Triple-Negative Breast Cancer: Results From the Phase I TROPION-PanTumor01 Study
2024 Standout
Cancer statistics, 2024
2024 Standout
Works of Julia Gable being referenced
Abstract P6-16-01: Health-related quality of life in MONARCH 3: Abemaciclib plus an aromatase inhibitor as initial therapy in women with HR+, HER2- advanced breast cancer
2019
Do tobacco countermarketing campaigns increase adolescent under-reporting of smoking?
2006
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Julia Gable | 114 | 229 | 7 | 108 | 17 | 342 | |
| Siobhan N. Perks | 95 | 278 | 1 | 80 | 18 | 358 | |
| Alexandria Smith | 95 | 241 | 10 | 140 | 15 | 397 | |
| Mary Salmon | 106 | 286 | 1 | 102 | 10 | 402 | |
| Rebecca Murphy-Hoefer | 70 | 233 | 1 | 126 | 14 | 301 | |
| Robert García | 142 | 276 | 5 | 48 | 18 | 397 | |
| LaTisha Marshall | 109 | 260 | 1 | 65 | 10 | 386 | |
| Shannon Carlin‐Menter | 119 | 363 | 203 | 16 | 410 | ||
| Rachel Kurtzman | 55 | 178 | 3 | 36 | 19 | 349 | |
| Aliya Noormohamed | 112 | 247 | 68 | 12 | 328 | ||
| Laura M. Mussulman | 107 | 255 | 11 | 101 | 20 | 383 |
All Works
Login with ORCID to disown or claim papers
Loading papers...